Last reviewed · How we verify
B: OLP-1002
At a glance
| Generic name | B: OLP-1002 |
|---|---|
| Also known as | OLP-1002: B |
| Sponsor | OliPass Australia Pty Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- B: OLP-1002 CI brief — competitive landscape report
- B: OLP-1002 updates RSS · CI watch RSS
- OliPass Australia Pty Ltd portfolio CI